Matrix metalloproteinase-9 and connective tissue growth factor and their role in progression of hepato-myocardial fibrosis in patients with stable coronary heart disease combined with nonalcoholic fatty liver disease

Abstract

Objective — to determine the regularities of the stable coronary heart disease (CHD) progression in condition of the formation of hepato­myocardial fibrosis by serum levels of matrix metalloproteinase-9 (MMP-9) and connective tissue growth factor (CTGF) against the background of nonalcoholic fatty liver disease (NAFLD). Materials and methods. Examinations involved 300 patients with stable CHD and chronic heart failure II—III class NYHA were examined: 160 patients without NAFLD (Group I); 140 patients with NAFLD (Groups II—V). Patients with NAFLD were divided depending on the liver fibrosis stage. Among the patients of each group, patients with nonalcoholic steatosis and nonalcoholic steatohepatitis (NASH) were selected. All patients underwent routine clinical examinations, electrocardiography, coronary angiography, echocardiography, liver elastography, evaluation of the liver functional state, measurement of serum NT-proBNP, MMP-9 and CTGF levels. Results and discussion. It has been established, that formation of the signs of postinfarction myocardium remodeling depended on the liver fibrosis stage and increased with the NAFLD progression. Serum MMP--9 and CTGF levels increased depending on the NAFLD course and liver fibrosis stage. In particular, in patients with nonalcoholic steatosis, serum MMP-9 level was higher vs. Group I by 13.2 % (at stage F1), by 17.5 % (at stage F2), by 25.8 % (at stage F3), and by 36.4 % (at F4 stage) respectively (p < 0.05). In patients of Groups IIA, IIIA and IVA, serum CTGF level was higher by 12.5, 17.1 and 26.4 % vs. Group I (p < 0.05) respectively. Against the NASH background, serum MMP-9 and CTGF levels were significantly higher not only vs. their levels in Group I, but also vs. patient with nonalcoholic steatosis of the respective groups. Conclusions. It has been established that peculiarities of the stable CHD course against the NAFLD background was the formation of postinfarction myocardium remodeling, the progression of which significantly depends on the liver fibrosis stage, as it is detected by serum NT-proBNP levels. The presence of a positive correlation between serum MMP-9, CTGF levels and serum NT-proBNP, left ventricular myocardial mass index, and left ventricular ejection fraction levels, indicated their direct involvement in the formation of hepato-myocardial fibrosis, making it possible to consider them as potential noninvasive markers for the fibrosis diagnosis in patients with stable CHD, combined with NAFLD.

Authors and Affiliations

І. І. Vakalyuk, N. G. Virstyuk

Keywords

Related Articles

The relationship between prolactin levels, sleep disorders and the effectiveness of glycaemia correction in patients with hypertension and type 2 diabetes mellitus

Objective — to assess sleep disorders in patients with hypertension and type 2 diabetes mellitus and to establish the role of prolactin in the formation of these changes. Materials and methods. The study included 63 pati...

The peculiarities of the treatment of patients with arterial hypertension and type 2 diabetes mellitus

Currently, arterial hypertension is established in more than a half of patients with diabetes. The presence of comorbid diseases requires an optimal treatment approach. The article provides an overview of current guideli...

Cardioprotective and antiatherogenic age-dependent growth differentiation factor 11 in patients with arterial hypertension in combination with obesity

Objective — to study the features of changes in the levels of growth differentiation factor 11 (FDR 11) in the blood of patients with arterial hypertension (AH) with abdominal obesity (AO) in comparison with the levels o...

Correlation between G894T polymorphism eNOS gene and development of periodontal pathology in patients with bronchialcardiac diseases

Objective — to establish possible connection between eNOS gene G894T polymorphism with a risk of pathology developing in the periodontal patients against the background of COPD comorbid with CHD. Materials and methods. T...

The peculiarities of heart remodeling in patients after myocardial infarction with ST-segment elevation depending on the Lys198Asn polymorphism of endothelin 1 gene

Objective — to investigate clinical and genetic aspects of associations of Lys198Asn endothelin 1 (EDN 1) gene polymorphism with the development of remodeling after myocardial infarction with ST-segment elevation (STEMI)...

Download PDF file
  • EP ID EP276348
  • DOI -
  • Views 100
  • Downloads 0

How To Cite

І. І. Vakalyuk, N. G. Virstyuk (2018). Matrix metalloproteinase-9 and connective tissue growth factor and their role in progression of hepato-myocardial fibrosis in patients with stable coronary heart disease combined with nonalcoholic fatty liver disease. Український терапевтичний журнал, 0(1), 25-31. https://europub.co.uk/articles/-A-276348